Product/Operations Update
PI Industries Unveils Pioxaniliprole
PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule, developed through over a decade of research and registered by CIB&RC.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
7
Bullish
4
Bearish
29
Neutral
7
Bullish
10
Bearish
26
Neutral
0
Bullish
6
Bearish
26
Neutral
0
Bullish
6
Bearish
26
Neutral
0
Bullish
6
Bearish
26
Neutral
0
Bullish
6
Upcoming Result Date: Nov 03, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone

P I Industries Ltd (PIIND) is currently trading at 2,089.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
PI Industries is an integrated agri‑sciences company and custom synthesis manufacturer providing crop protection solutions, biologicals, electronic/performance chemicals and emerging CRDMO services; its operations include multi‑product manufacturing plants in Gujarat, an R&D centre in Udaipur, global subsidiaries and recent acquisitions expanding pharma and biologics capabilities. PI Industries reported Q1 FY27 revenue of INR 17,023 million, a gross margin of 57% and an EBITDA margin of 22%, while remaining net cash positive with INR 38 billion, reflecting strong balance‑sheet flexibility despite cyclical headwinds in exports. The company is visibly pivoting into higher‑value adjacencies: PI Industries launched Pioxaniliprole (first Indian NCE for crop protection), is commercializing biologicals with a unique foliar nematicide registered in Brazil, Mexico and the US, and is building CRDMO services via acquisitions like Archimica for future pharma revenue. PI Industries is investing aggressively in capability‑led differentiation — commissioning one of the world’s largest flow chemistry plants, scaling biologics field trials (500+ trials, 1,000+ grower engagements) and targeting digital and AI tools to accelerate discovery and safe manufacturing, signalling a strategic shift from commodity to technology‑led offerings.
Over the past 52 weeks, P I Industries Ltd has traded between a low of ₹2,006.00 and a high of ₹3,829.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
P I Industries Ltd has a market capitalization of approximately 32,012.52. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
P I Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 27.48 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 32,012.52 Cr, P I Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
P I Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of P I Industries Ltd is 27.48. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The provided snapshot lists PI Industries at Rs 2,465, up Rs 45.10 (1.86%) as of 04 Sep, 4:00 PM on the NSE.
The earnings call was held on August 12, 2026, and it covered unaudited results for the quarter ended June 30, 2026.
PI Industries trades as PIIND on NSE and 523642 on BSE, as shown in the provided data.
For FY26 ended March 31, 2026, PI Industries reported consolidated revenue from operations of ₹67,137 million and consolidated PAT of ₹13,208 million.

Product/Operations Update
PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule, developed through over a decade of research and registered by CIB&RC.
Earnings Call/Transcript
P I Industries will host an earnings conference call on November 5, 2026, at 12:00 noon IST to discuss Q2 FY27 results with analysts and investors.
Earnings Call/Transcript
P I Industries will hold an earnings conference call on November 5, 2026, at 12:00 noon IST, following results for the quarter and half year ended September 30, 2026.
Board Meeting
P I Industries will consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, on November 4, 2026.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
31,694 Cr
Moderate Risk
27.2
18.4
2.2
2.9
3,829.90
2,006.00
Sales CAGR
Profit CAGR
ROE
ROCE